相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Melatonin as a chronobiotic/cytoprotector: its role in healthy aging
Daniel P. Cardinali
BIOLOGICAL RHYTHM RESEARCH (2019)
Exogenous melatonin as a treatment for secondary sleep disorders: A systematic review and meta-analysis
Tian Li et al.
FRONTIERS IN NEUROENDOCRINOLOGY (2019)
The role of melatonin in targeting cell signaling pathways in neurodegeneration
Mayuri Shukla et al.
ANNALS OF THE NEW YORK ACADEMY OF SCIENCES (2019)
Emerging pathways to neurodegeneration: Dissecting the critical molecular mechanisms in Alzheimer's disease, Parkinson's disease
Sean Hong Tan et al.
BIOMEDICINE & PHARMACOTHERAPY (2019)
CSF α-synuclein inversely correlates with non-motor symptoms in a cohort of PD patients
Tommaso Schirinzi et al.
PARKINSONISM & RELATED DISORDERS (2019)
α-Synuclein nonhuman primate models of Parkinson's disease
David J. Marmion et al.
JOURNAL OF NEURAL TRANSMISSION (2018)
Chronic MPTP administration regimen in monkeys: a model of dopaminergic and non-dopaminergic cell loss in Parkinson's disease
Gunasingh J. Masilamoni et al.
JOURNAL OF NEURAL TRANSMISSION (2018)
Neuroprotective effects of melatonin on amphetamine-induced dopaminergic fiber degeneration in the hippocampus of postnatal rats
Tanawan Leeboonngam et al.
JOURNAL OF PINEAL RESEARCH (2018)
Twenty Years After: Another Case Report of Melatonin Effects on REM Sleep Behavior Disorder, Using Serial Dopamine Transporter Imaging
Dieter Kunz et al.
NEUROPSYCHOBIOLOGY (2018)
Melatonin improves survival and respiratory activity of yeast cells challenged by alpha-synuclein and menadione
Mariana A. Zampol et al.
YEAST (2018)
Interventional programmes to improve cognition during healthy and pathological ageing: Cortical modulations and evidence for brain plasticity
Jesus Cespon et al.
AGEING RESEARCH REVIEWS (2018)
The Emerging Relationship Between Interstitial Fluid-Cerebrospinal Fluid Exchange, Amyloid-beta, and Sleep
Erin L. Boespflug et al.
BIOLOGICAL PSYCHIATRY (2018)
Emerging preclinical interest concerning the role of circadian function in Parkinson's disease
Gregory L. Willis et al.
BRAIN RESEARCH (2018)
Melatonin Treatment Enhances A beta Lymphatic Clearance in a Transgenic Mouse Model of Amyloidosis
M. A. Pappolla et al.
CURRENT ALZHEIMER RESEARCH (2018)
The Glymphatic System in Central Nervous System Health and Disease: Past, Present, and Future
Benjamin A. Plog et al.
ANNUAL REVIEW OF PATHOLOGY: MECHANISMS OF DISEASE, VOL 13 (2018)
Melatonin ameliorates Aβ42-induced alteration of βAPP-processing secretases via the melatonin receptor through the Pin1/GSK3β/NF-κB pathway in SH-SY5Y cells
Vorapin Chinchalongporn et al.
JOURNAL OF PINEAL RESEARCH (2018)
Melatonin protects against behavioral deficits, dopamine loss and oxidative stress in homocysteine model of Parkinson's disease
Rajib Paul et al.
LIFE SCIENCES (2018)
Off-label and unlicensed prescribing in Europe: implications for patients' informed consent and liability
Lise Aagaard et al.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY (2018)
Melatonin Mitigates Mitochondrial Meltdown: Interactions with SIRT3
Russel J. Reiter et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Melatonin and inflammation-Story of a double-edged blade
Ruediger Hardeland
JOURNAL OF PINEAL RESEARCH (2018)
Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing
Barry Boland et al.
NATURE REVIEWS DRUG DISCOVERY (2018)
Non-Dopaminergic Therapies
John G. Nutt et al.
JOURNAL OF PARKINSONS DISEASE (2018)
Melatonin receptors: molecular pharmacology and signalling in the context of system bias
Erika Cecon et al.
BRITISH JOURNAL OF PHARMACOLOGY (2018)
Expression of Aquaporin 1 and Aquaporin 4 in the Temporal Neocortex of Patients with Parkinson's Disease
Akihiko Hoshi et al.
BRAIN PATHOLOGY (2017)
The effect of melatonin on early postoperative cognitive decline in elderly patients undergoing hip arthroplasty: A randomized controlled trial
Yunxia Fan et al.
JOURNAL OF CLINICAL ANESTHESIA (2017)
Off-label drug use in oncology: a systematic review of literature
M. M. Saiyed et al.
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS (2017)
Diagnosing early cognitive decline-When, how and for whom?
Charlotte L. Allan et al.
MATURITAS (2017)
Mitochondrial impairment and melatonin protection in parkinsonian mice do not depend of inducible or neuronal nitric oxide synthases
Ana Lopez et al.
PLOS ONE (2017)
Dual role of mitochondria in producing melatonin and driving GPCR signaling to block cytochrome c release
Yalikun Suofu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Evidence for the efficacy of melatonin in the treatment of primary adult sleep disorders
Fiona Auld et al.
SLEEP MEDICINE REVIEWS (2017)
The Oxygen Paradox, the French Paradox, and age-related diseases
Joanna M. S. Davies et al.
GEROSCIENCE (2017)
Effects of Melatonin Levels on Neurotoxicity of the Medial Prefrontal Cortex in a Rat Model of Parkinson's Disease
Yan Li et al.
CHINESE MEDICAL JOURNAL (2017)
Melatonin as a mitochondria-targeted antioxidant: one of evolution's best ideas
Russel J. Reiter et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2017)
Alpha-synuclein, epigenetics, mitochondria, metabolism, calcium traffic, & circadian dysfunction in Parkinson's disease. An integrated strategy for management
Oliver T. Phillipson
AGEING RESEARCH REVIEWS (2017)
Melatonin Effects in REM Sleep Behavior Disorder Associated with Obstructive Sleep Apnea Syndrome: A Case Series
Carolin Schaefer et al.
CURRENT ALZHEIMER RESEARCH (2017)
Melatonin receptors: distribution in mammalian brain and their respective putative functions
Khuen Yen Ng et al.
BRAIN STRUCTURE & FUNCTION (2017)
Melatonin ameliorates anxiety and depression-like behaviors and modulates proteomic changes in triple transgenic mice of Alzheimer's disease
Lulin Nie et al.
BIOFACTORS (2017)
Pharmacokinetics of High-Dose Intravenous Melatonin in Humans
Lars P. H. Andersen et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2016)
Exogenous melatonin for sleep disorders in neurodegenerative diseases: a meta-analysis of randomized clinical trials
Wei Zhang et al.
NEUROLOGICAL SCIENCES (2016)
Chronic low-dose melatonin treatment maintains nigrostriatal integrity in an intrastriatal rotenone model of Parkinson's disease
Candace H. Carriere et al.
BRAIN RESEARCH (2016)
Treatment of Sleep Disorders in Dementia
Sharon Ooms et al.
CURRENT TREATMENT OPTIONS IN NEUROLOGY (2016)
Glymphatic distribution of CSF-derived apoE into brain is isoform specific and suppressed during sleep deprivation
Thiyagaragan M. Achariyar et al.
MOLECULAR NEURODEGENERATION (2016)
Understanding Dopaminergic Cell Death Pathways in Parkinson Disease
Patrick P. Michel et al.
NEURON (2016)
Melatoninergic System in Parkinson's Disease: From Neuroprotection to the Management of Motor and Nonmotor Symptoms
Josiel Mileno Mack et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2016)
α-Synuclein-Based Animal Models of Parkinson's Disease: Challenges and Opportunities in a New Era
Naomi P. Visanji et al.
TRENDS IN NEUROSCIENCES (2016)
Curcumin/Melatonin Hybrid 5-(4-Hydroxy-phenyl)-3-oxo-pentanoic Acid [2-(5-Methoxy-1H-indol-3-yl)-ethyl]-amide Ameliorates AD-Like Pathology in the APP/PS1 Mouse Model
Gorka Gerenu et al.
ACS CHEMICAL NEUROSCIENCE (2015)
Melatonin for Sleep Disorders and Cognition in Dementia: A Meta-Analysis of Randomized Controlled Trials
Jing Xu et al.
AMERICAN JOURNAL OF ALZHEIMERS DISEASE AND OTHER DEMENTIAS (2015)
REM sleep behaviour disorder: a window on the sleeping brain
Mark W. Mahowald et al.
BRAIN (2015)
A Multicenter Evaluation of Off-Label Medication Use and Associated Adverse Drug Reactions in Adult Medical ICUs
Pamela L. Smithburger et al.
CRITICAL CARE MEDICINE (2015)
Melatonin is protective against 6-hydroxydopamine-induced oxidative stress in a hemiparkinsonian rat model
O. Ozsoy et al.
FREE RADICAL RESEARCH (2015)
Melatonin enhances L-DOPA therapeutic effects, helps to reduce its dose, and protects dopaminergic neurons in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism in mice
Amit Naskar et al.
JOURNAL OF PINEAL RESEARCH (2015)
Melatonin treatment improves primary progressive multiple sclerosis: a case report
Antonio Lopez-Gonzalez et al.
JOURNAL OF PINEAL RESEARCH (2015)
Melatonin regulates the transcription of βAPP-cleaving secretases mediated through melatonin receptors in human neuroblastoma SH-SY5Y cells
Jiraporn Panmanee et al.
JOURNAL OF PINEAL RESEARCH (2015)
Melatonin: an ancient molecule that makes oxygen metabolically tolerable
Lucien C. Manchester et al.
JOURNAL OF PINEAL RESEARCH (2015)
Functions of melatonin in plants: a review
Marino B. Arnao et al.
JOURNAL OF PINEAL RESEARCH (2015)
Changes in cognitive symptoms after a buspirone-melatonin combination treatment for Major Depressive Disorder
Steven D. Targum et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2015)
The Glymphatic System: A Beginner's Guide
Nadia Aalling Jessen et al.
NEUROCHEMICAL RESEARCH (2015)
Melatonin: Physiological effects in humans
B. Claustrat et al.
NEUROCHIRURGIE (2015)
Effect of melatonin on sleep disorders in a monkey model of Parkinson's disease
Hayat Belaid et al.
SLEEP MEDICINE (2015)
Plasma 8-isoPGF2α and serum melatonin levels in patients with minimal cognitive impairment and Alzheimer disease
Fevziye Burcu Sirin et al.
TURKISH JOURNAL OF MEDICAL SCIENCES (2015)
Beneficial effects of melatonin in a rat model of sporadic Alzheimer's disease
Ekaterina A. Rudnitskaya et al.
BIOGERONTOLOGY (2015)
Melatonin stimulates the nonamyloidogenic processing of βAPP through the positive transcriptional regulation of ADAM10 and ADAM17
Mayuri Shukla et al.
JOURNAL OF PINEAL RESEARCH (2015)
A new balancing act: The many roles of melatonin and serotonin in plant growth and development
Lauren A. E. Erland et al.
PLANT SIGNALING & BEHAVIOR (2015)
Neuroprotective and antidepressant-like effects of melatonin in a rotenone-induced Parkinson's disease model in rats
Taysa B. Bassani et al.
BRAIN RESEARCH (2014)
Extrapineal melatonin: sources, regulation, and potential functions
Dario Acuna-Castroviejo et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2014)
Chronic exposure to aluminum and melatonin through the diet: Neurobehavioral effects in a transgenic mouse model of Alzheimer disease
Celeste Di Paolo et al.
FOOD AND CHEMICAL TOXICOLOGY (2014)
Fundamental Issues Related to the Origin of Melatonin and Melatonin Isomers during Evolution: Relation to Their Biological Functions
Dun-Xian Tan et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2014)
Impairment of Glymphatic Pathway Function Promotes Tau Pathology after Traumatic Brain Injury
Jeffrey J. Iliff et al.
JOURNAL OF NEUROSCIENCE (2014)
Melatonin identified in meats and other food stuffs: potentially nutritional impact
Dun-Xian Tan et al.
JOURNAL OF PINEAL RESEARCH (2014)
Melatonin as a potential therapy for sepsis: a phase I dose escalation study and an ex vivo whole blood model under conditions of sepsis
Helen F. Galley et al.
JOURNAL OF PINEAL RESEARCH (2014)
Mechanism of the beneficial effect of melatonin in experimental Parkinson's disease
Fatos Belgin Yildirim et al.
NEUROCHEMISTRY INTERNATIONAL (2014)
Circadian Melatonin Rhythm and Excessive Daytime Sleepiness in Parkinson Disease
Aleksandar Videnovic et al.
JAMA NEUROLOGY (2014)
Add-on prolonged-release melatonin for cognitive function and sleep in mild to moderate Alzheimer's disease: a 6-month, randomized, placebo-controlled, multicenter trial
Alan G. Wade et al.
CLINICAL INTERVENTIONS IN AGING (2014)
Association of AMD-like retinopathy development with an Alzheimer's disease metabolic pathway in OXYS rats
Oyuna S. Kozhevnikova et al.
BIOGERONTOLOGY (2013)
Melatonin: Buffering the Immune System
Antonio Carrillo-Vico et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2013)
Analysis of the daily changes of melatonin receptors in the rat liver
Carmen Venegas et al.
JOURNAL OF PINEAL RESEARCH (2013)
Melatonin synergizes with low doses of L-DOPA to improve dendritic spine density in the mouse striatum in experimental Parkinsonism
Amit Naskar et al.
JOURNAL OF PINEAL RESEARCH (2013)
Meta-Analysis: Melatonin for the Treatment of Primary Sleep Disorders
Eduardo Ferracioli-Oda et al.
PLOS ONE (2013)
Antioxidant potential of melatonin enhances the response to L-dopa in 1-methyl 4-phenyl 1,2,3,6-tetrahydropyridine-parkinsonian mice
Sawsan A. Zaitone et al.
PHARMACOLOGICAL REPORTS (2013)
Rapid eye movement sleep behavior disorder: devising controlled active treatment studies for symptomatic and neuroprotective therapy-a consensus statement from the International Rapid Eye Movement Sleep Behavior Disorder Study Group
C. H. Schenck et al.
SLEEP MEDICINE (2013)
Treatment outcomes in REM sleep behavior disorder
Stuart J. McCarter et al.
SLEEP MEDICINE (2013)
Circadian System Functionality, Hippocampal Oxidative Stress, and Spatial Memory in the APPswe/PS1dE9 Transgenic Model of Alzheimer Disease: Effects of Melatonin or Ramelteon
Beatriz Bano Otalora et al.
CHRONOBIOLOGY INTERNATIONAL (2012)
Effects of DHA-phospholipids, melatonin and tryptophan supplementation on erythrocyte membrane physico-chemical properties in elderly patients suffering from mild cognitive impairment
Roberta Cazzola et al.
EXPERIMENTAL GERONTOLOGY (2012)
Melatonin Modulates the GABAergic Response in Cultured Rat Hippocampal Neurons
Xin-Ping Cheng et al.
JOURNAL OF PHARMACOLOGICAL SCIENCES (2012)
Human responses to bright light of different durations
Anne-Marie Chang et al.
JOURNAL OF PHYSIOLOGY-LONDON (2012)
Melatonin reduces the expression of alpha-synuclein in the dopamine containing neuronal regions of amphetamine-treated postnatal rats
Kwankanit Sae-Ung et al.
JOURNAL OF PINEAL RESEARCH (2012)
Melatonin attenuates kainic acid-induced neurotoxicity in mouse hippocampus via inhibition of autophagy and a-synuclein aggregation
Chia-Fu Chang et al.
JOURNAL OF PINEAL RESEARCH (2012)
Melatonin plus physical exercise are highly neuroprotective in the 3xTg-AD mouse
Yoelvis Garcia-Mesa et al.
NEUROBIOLOGY OF AGING (2012)
Sleep Disturbances in Alzheimer's and Parkinson's Diseases
Sarah M. Rothman et al.
NEUROMOLECULAR MEDICINE (2012)
Caffeine increases mitochondrial function and blocks melatonin signaling to mitochondria in Alzheimer's mice and cells
Natasa Dragicevic et al.
NEUROPHARMACOLOGY (2012)
Melatonin modulates cytoskeletal organization in the rat brain hippocampus
Graciela Jimenez-Rubio et al.
NEUROSCIENCE LETTERS (2012)
Effects of a diet integration with an oily emulsion of DHA-phospholipids containing melatonin and tryptophan in elderly patients suffering from mild cognitive impairment
Mariangela Rondanelli et al.
NUTRITIONAL NEUROSCIENCE (2012)
Marked improvement in delirium with ramelteon: five case reports
Motohide Furuya et al.
PSYCHOGERIATRICS (2012)
A Paravascular Pathway Facilitates CSF Flow Through the Brain Parenchyma and the Clearance of Interstitial Solutes, Including Amyloid β
Jeffrey J. Iliff et al.
SCIENCE TRANSLATIONAL MEDICINE (2012)
Melatonin treatment counteracts the hyperoxidative status in erythrocytes of patients suffering from Duchenne muscular dystrophy
Mariam Chahbouni et al.
CLINICAL BIOCHEMISTRY (2011)
Inhibition of the bioactivation of the neurotoxin MPTP by antioxidants, redox agents and monoamine oxidase inhibitors
Tomas Herraiz et al.
FOOD AND CHEMICAL TOXICOLOGY (2011)
Melatonin or silymarin reduces maneb- and paraquat-induced Parkinson's disease phenotype in the mouse
Naveen Kumar Singhal et al.
JOURNAL OF PINEAL RESEARCH (2011)
Melatonin treatment restores mitochondrial function in Alzheimer's mice: a mitochondrial protective role of melatonin membrane receptor signaling
Natasa Dragicevic et al.
JOURNAL OF PINEAL RESEARCH (2011)
Melatonin reduces the impairment of axonal transport and axonopathy induced by calyculin A
Yu-Fang Xiong et al.
JOURNAL OF PINEAL RESEARCH (2011)
The use of high-dose melatonin in liver resection is safe: first clinical experience
Arash Nickkholgh et al.
JOURNAL OF PINEAL RESEARCH (2011)
Melatonin as a natural ally against oxidative stress: a physicochemical examination
Annia Galano et al.
JOURNAL OF PINEAL RESEARCH (2011)
Increasing off-label use of antipsychotic medications in the United States, 1995-2008
G. C. Alexander et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2011)
Melatonin protects against neurobehavioral and mitochondrial deficits in a chronic mouse model of Parkinson's disease
Gaurav Patki et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2011)
Altered temporal patterns of anxiety in aged and amyloid precursor protein (APP) transgenic mice
Tracy A. Bedrosian et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Melatonin-A pleiotropic, orchestrating regulator molecule
Ruediger Hardeland et al.
PROGRESS IN NEUROBIOLOGY (2011)
Parkinson's Disease as a Neuroendocrine Disorder of Circadian Function: Dopamine-Melatonin Imbalance and the Visual System in the Genesis and Progression of the Degenerative Process
Gregory L. Willis
REVIEWS IN THE NEUROSCIENCES (2011)
Cadmium-Induced Disruption in 24-h Expression of Clock and Redox Enzyme Genes in Rat Medial Basal Hypothalamus: Prevention by Melatonin
Vanesa Jiménez-Ortega et al.
Frontiers in Neurology (2011)
Scientific Opinion on the substantiation of a health claim related to melatonin and reduction of sleep onset latency (ID 1698, 1780, 4080) pursuant to Article 13(1) of Regulation (EC) No 1924/2006
Carlo Agostoni et al.
EFSA JOURNAL (2011)
Posttreatment with uridine and melatonin following traumatic brain injury reduces edema in various brain regions in rats
Shruti V. Kabadi et al.
NEUROPROTECTIVE AGENTS (2010)
Clinical Aspects of Melatonin Intervention in Alzheimers Disease Progression
Daniel P. Cardinali et al.
Current Neuropharmacology (2010)
Neurotoxins: Free Radical Mechanisms and Melatonin Protection
Russel J. Reiter et al.
Current Neuropharmacology (2010)
Oxidative Stress Status and RNA Expression in Hippocampus of an Animal Model of Alzheimer's disease After Chronic Exposure to Aluminum
Tania Garcia et al.
HIPPOCAMPUS (2010)
British Association for Psychopharmacology consensus statement on evidence-based treatment of insomnia, parasomnias and circadian rhythm disorders
S. J. Wilson et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2010)
A two-part, double-blind, placebo-controlled trial of exogenous melatonin in REM sleep behaviour disorder
Dieter Kunz et al.
JOURNAL OF SLEEP RESEARCH (2010)
A New Tacrine-Melatonin Hybrid Reduces Amyloid Burden and Behavioral Deficits in a Mouse Model of Alzheimer's Disease
Carlos Spuch et al.
NEUROTOXICITY RESEARCH (2010)
International Union of Basic and Clinical Pharmacology. LXXV. Nomenclature, Classification, and Pharmacology of G Protein-Coupled Melatonin Receptors
Margarita L. Dubocovich et al.
PHARMACOLOGICAL REVIEWS (2010)
Scientific Opinion on the substantiation of health claims related to melatonin and alleviation of subjective feelings of jet lag (ID 1953), and reduction of sleep onset latency, and improvement of sleep quality (ID 1953) pursuant to Article 13(1) of Regulation (EC) No 1924/2006
Carlo Agostoni et al.
EFSA JOURNAL (2010)
Off-Label Prescribing to Children in the United States Outpatient Setting
Alicia T. F. Bazzano et al.
ACADEMIC PEDIATRICS (2009)
Melatonin Fails to Improve Sleep or Agitation in Double-Blind Randomized Placebo-Controlled Trial of Institutionalized Patients With Alzheimer Disease
Philip R. Gehrman et al.
AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY (2009)
Fibroblast growth factor 9 prevents MPP+-induced death of dopaminergic neurons and is involved in melatonin neuroprotection in vivo and in vitro
Jui-Yen Huang et al.
JOURNAL OF NEUROCHEMISTRY (2009)
Melatonin and Its Brain Metabolite N1-Acetyl-5-Methoxykynuramine Prevent Mitochondrial Nitric Oxide Synthase Induction in Parkinsonian Mice
Victor Tapias et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2009)
Preoperative Anxiolytic Effect of Melatonin and Clonidine on Postoperative Pain and Morphine Consumption in Patients Undergoing Abdominal Hysterectomy: A Double-Blind, Randomized, Placebo-Controlled Study
Wolnei Caumo et al.
JOURNAL OF PAIN (2009)
Protection against cognitive deficits and markers of neurodegeneration by long-term oral administration of melatonin in a transgenic model of Alzheimer disease
James M. Olcese et al.
JOURNAL OF PINEAL RESEARCH (2009)
Evaluation of the protective role of melatonin on the behavioral effects of aluminum in a mouse model of Alzheimer's disease
Tania Garcia et al.
TOXICOLOGY (2009)
REM sleep behaviour disorder treated with melatonin in a patient with Alzheimer's disease
Kirstie N. Anderson et al.
CLINICAL NEUROLOGY AND NEUROSURGERY (2008)
Dose translation from animal to human studies revisited
Shannon Reagan-Shaw et al.
FASEB JOURNAL (2008)
Effect of bright light and melatonin on cognitive and noncognitive function in elderly residents of group care facilities - A randomized controlled trial
Rixt F. Riemersma-van der Lek et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2008)
Melatonin and bright-light treatment for rest-activity disruption in institutionalized patients with Alzheimer's disease
Glenna A. Dowling et al.
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2008)
Melatonin inhibits amphetamine-induced increase in α-synuclein and decrease in phosphorylated tyrosine hydroxylase in SK-N-SH cells
Sirirat Klongpanichapak et al.
NEUROSCIENCE LETTERS (2008)
Physiological effects of melatonin: Role of melatonin receptors and signal transduction pathways
Seithikurippu R. Pandi-Perumal et al.
PROGRESS IN NEUROBIOLOGY (2008)
Possible therapeutic value of melatonin in mild cognitive impairment: a retrospective study
Analia M. Furio et al.
JOURNAL OF PINEAL RESEARCH (2007)
Efficacy of prolonged release melatonin in insomnia patients aged 55-80 years: quality of age sleep and next-day alertness outcomes
Alan G. Wade et al.
CURRENT MEDICAL RESEARCH AND OPINION (2007)
Melatonin attenuates arsenite-induced apoptosis in rat brain:: involvement of mitochondrial and endoplasmic reticulum pathways and aggregation of α-synuclein
Anya M. Y. Lin et al.
JOURNAL OF PINEAL RESEARCH (2007)
Actigraphy in agitated patients with dementia - Monitoring treatment outcomes
R. Mahlberg et al.
ZEITSCHRIFT FUR GERONTOLOGIE UND GERIATRIE (2007)
Melatonin protects against rotenone-induced oxidative stress in a hemiparkinsonian rat model
Karuppagounder S. Saravanan et al.
JOURNAL OF PINEAL RESEARCH (2007)
Effect of exogenous melatonin on sleep and motor dysfunction in Parkinson's disease - A randomized, double blind, placebo-controlled study
Camila Andrade Mendes Medeiros et al.
JOURNAL OF NEUROLOGY (2007)
Primary and secondary features of Parkinson's disease improve with strategic exposure to bright light: A case series study
Gregory L. Willis et al.
CHRONOBIOLOGY INTERNATIONAL (2007)
Reduced oxidative damage in ALS by high-dose enteral melatonin treatment
Jochen H. Weishaupt et al.
JOURNAL OF PINEAL RESEARCH (2006)
In vivo protective effect of melatonin on cadmium-induced changes in redox balance and gene expression in rat hypothalamus and anterior pituitary
Ariel H. B. Poliandri et al.
JOURNAL OF PINEAL RESEARCH (2006)
Melatonin suppresses macrophage cyclooxygenase-2 and inducible nitric oxide synthase expression by inhibiting p52 acetylation and binding
Wu-Guo Deng et al.
BLOOD (2006)
Rapid-eye-movement sleep behaviour disorder as an early marker for a neurodegenerative disorder:: a descriptive study
Alex Iranzo et al.
LANCET NEUROLOGY (2006)
Complementary medicines in psychiatry. Review of effectiveness and safety
U Werneke et al.
BRITISH JOURNAL OF PSYCHIATRY (2006)
Physiological neuroprotection by melatonin in a 6-hydroxydopamine model of Parkinson's disease
R Sharma et al.
BRAIN RESEARCH (2006)
Early melatonin supplementation alleviates oxidative stress in a transgenic mouse model of Alzheimer's disease
Z Feng et al.
FREE RADICAL BIOLOGY AND MEDICINE (2006)
Circadian uses of melatonin in humans
A Lewy et al.
CHRONOBIOLOGY INTERNATIONAL (2006)
Melatonin for sleep disturbances in Parkinson's disease
GA Dowling et al.
SLEEP MEDICINE (2005)
Effects of melatonin on wortmannin-induced tau hyperphosphorylation
YQ Deng et al.
ACTA PHARMACOLOGICA SINICA (2005)
Chronic melatonin therapy fails to alter amyloid burden or oxidative damage in old Tg2576 mice:: Implications for clinical trials
J Quinn et al.
BRAIN RESEARCH (2005)
The human MT1 melatonin receptor stimulates cAMP production in the human neuroblastoma cell line SH-SY5Y cells via a calcium-calmodulin signal transduction pathway
C Schuster et al.
JOURNAL OF NEUROENDOCRINOLOGY (2005)
Recovery from experimental Parkinson's disease in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine hydrochloride treated marmoset with the melatonin analogue ML-23
GL Willis et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2005)
Light at night and cancer risk
E Schernhammer et al.
PHOTOCHEMISTRY AND PHOTOBIOLOGY (2004)
Melatonin protects SH-SY5Y neuroblastoma cells from calyculin A-induced neurofilament impairment and neurotoxicity
SP Li et al.
JOURNAL OF PINEAL RESEARCH (2004)
Taurine prevents the neurotoxicity of β-amyloid and glutamate receptor agonists:: activation of GABA receptors and possible implications for Alzheimer's disease and other neurological disorders
PR Louzada et al.
FASEB JOURNAL (2004)
Nocturnal 6-sulfatoxymelatonin excretion in insomnia and its relation to the response to melatonin replacement therapy
D Leger et al.
AMERICAN JOURNAL OF MEDICINE (2004)
Melatonin alleviates behavioral deficits associated with apoptosis and cholinergic system dysfunction in the APP 695 transgenic mouse model of Alzheimer's disease
Z Feng et al.
JOURNAL OF PINEAL RESEARCH (2004)
Melatonin treatment of day-night rhythm disturbances and sundowning in Alzheimer disease -: An open-label pilot study using actigraphy
R Mahlberg et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2004)
Cognitive effects of exogenous melatonin administration in elderly persons - A pilot study
JS Peck et al.
AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY (2004)
Protective effect of melatonin on β-amyloid-induced apoptosis in rat astroglioma C6 cells and its mechanism
Z Feng et al.
FREE RADICAL BIOLOGY AND MEDICINE (2004)
Mechanisms of N-methyl-D-aspartate receptor inhibition by melatonin in the rat striatum
G Escames et al.
JOURNAL OF NEUROENDOCRINOLOGY (2004)
Melatonin-induced neuroprotection after closed head injury is associated with increased brain antioxidants and attenuated late-phase activation of NF-kappa B and AP-1
SM Beni et al.
FASEB JOURNAL (2004)
Delayed treatment with melatonin enhances electrophysiological recovery following transient focal cerebral ischemia in rats
EJ Lee et al.
JOURNAL OF PINEAL RESEARCH (2004)
Protective effects of melatonin and vitamin E in brain damage due to gamma radiation - An experimental study
FS Erol et al.
NEUROSURGICAL REVIEW (2004)
Melatonin prevents free radical formation due to the interaction between β-amyloid peptides and metal ions [Al(III), Zn(II), Cu(II), Mn(II), Fe(II)]
P Zatta et al.
JOURNAL OF PINEAL RESEARCH (2003)
Orally administered melatonin reduces oxidative stress and proinflammatory cytokines induced by amyloid-β peptide in rat brain:: a comparative, in vivo study versus vitamin C and E
S Rosales-Corral et al.
JOURNAL OF PINEAL RESEARCH (2003)
Melatonin for treatment of REM sleep behavior disorder in neurologic disorders: results in 14 patients
BF Boeve et al.
SLEEP MEDICINE (2003)
Melatonin prevents cytoskeletal alterations and oxidative stress induced by okadaic acid in N1E-115 cells
G Benitez-King et al.
EXPERIMENTAL NEUROLOGY (2003)
Melatonin increases survival and inhibits oxidative and amyloid pathology in a transgenic model of Alzheimer's disease
E Matsubara et al.
JOURNAL OF NEUROCHEMISTRY (2003)
Protective melatonin effect on oxidative stress induced by okadaic acid into rat brain
I Túnez et al.
JOURNAL OF PINEAL RESEARCH (2003)
Synergistic effects of melatonin and deprenyl against MPTP-induced mitochondrial damage and DA depletion
H Khaldy et al.
NEUROBIOLOGY OF AGING (2003)
Study of circadian melatonin secretion pattern at different stages of Parkinson's disease
R Bordet et al.
CLINICAL NEUROPHARMACOLOGY (2003)
A multicenter, placebo-controlled trial of melatonin for sleep disturbance in Alzheimer's disease
C Singer et al.
SLEEP (2003)
Double blind randomised placebo controlled trial of low dose melatonin for sleep disorders in dementia
M Serfaty et al.
INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY (2002)
Effect of melatonin on changes in locomotor activity rhythm of Syrian hamsters injected with beta amyloid peptide 25-35 in the Suprachiasmatic nuclei
AM Furio et al.
CELLULAR AND MOLECULAR NEUROBIOLOGY (2002)
Melatonin as a candidate compound for neuroprotection in amyotrophic lateral sclerosis (ALS):: high tolerability of daily oral melatonin administration in ALS patients
S Jacob et al.
JOURNAL OF PINEAL RESEARCH (2002)
Melatonin attenuates MPP+-induced neurodegeneration and glutathione impairment in the nigrostriatal dopaminergic pathway
ST Chen et al.
JOURNAL OF PINEAL RESEARCH (2002)
Melatonin blocks rat hippocampal neuronal apoptosis induced by amyloid beta-peptide 25-35
YX Shen et al.
JOURNAL OF PINEAL RESEARCH (2002)
Melatonin reverses neurochemical alterations induced by 6-OHDA in rat striatum
LMV Aguiar et al.
LIFE SCIENCES (2002)
Melatonin mt1 and MT2 receptors stimulate c-Jun N-terminal kinase via pertussis toxin-sensitive and -insensitive G proteins
ASL Chan et al.
CELLULAR SIGNALLING (2002)
Melatonin reverses the profibrillogenic activity of apolipoprotein E4 on the Alzheimer amyloid Aβ peptide
B Poeggeler et al.
BIOCHEMISTRY (2001)
Melatonin therapy for REM sleep behavior disorder
N Takeuchi et al.
PSYCHIATRY AND CLINICAL NEUROSCIENCES (2001)
Melatonin protects against 6-OHDA-induced neurotoxicity in rats: a role for mitochondrial complex I activity
F Dabbeni-Sala et al.
FASEB JOURNAL (2001)
Melatonin for treatment of sundowning in elderly persons with dementia - a preliminary study
J Cohen-Mansfield et al.
ARCHIVES OF GERONTOLOGY AND GERIATRICS (2000)
Supplementary administration of artificial bright light and melatonin as potent treatment for disorganized circadian rest-activity and dysfunctional autonomic and neuroendocrine systems in institutionalized demented elderly persons
K Mishima et al.
CHRONOBIOLOGY INTERNATIONAL (2000)
分享论文
